Continuous Glucose Monitoring: Current Use and Future Directions

被引：51

作者：

DeSalvo, Daniel ^{[1
]}

Buckingham, Bruce ^{[1
]}

机构：

[1] Stanford Med Ctr, Dept Pediat Endocrinol & Diabet, Stanford, CA 94305 USA

来源：

CURRENT DIABETES REPORTS | 2013年 / 13卷 / 05期

关键词：

Type; 1; diabetes; Continuous glucose monitoring; Closed-loop system; Artificial pancreas; Nocturnal hypoglycemia; CRITICALLY-ILL PATIENTS; INSULIN-PUMP THERAPY; REAL-TIME; GLYCEMIC CONTROL; HYPOGLYCEMIA UNAWARENESS; EPINEPHRINE RESPONSES; RANDOMIZED-TRIAL; IN-VIVO; SENSOR; CHILDREN;

D O I：

10.1007/s11892-013-0398-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Continuous glucose monitoring (CGM) is an emerging technology that provides a continuous measure of interstitial glucose levels. In addition to providing a more complete pattern of glucose excursions, CGMs utilize real-time alarms for thresholds and predictions of hypo- and hyperglycemia, as well as rate of change alarms for rapid glycemic excursions. CGM users have been able to improve glycemic control without increasing their risk of hypoglycemia. Sensor accuracy, reliability, and wearability are important challenges to CGM success and are critical to the development of an artificial pancreas (or closed-loop system).

引用

页码：657 / 662

页数：6

共 48 条

[31] Improving Epinephrine Responses in Hypoglycemia Unawareness With Real-Time Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes [J].

Ly, Trang T. ;

Hewitt, Jacqueline ;

Davey, Raymond J. ;

Lim, Ee Mun ;

Davis, Elizabeth A. ;

Jones, Timothy W. .

DIABETES CARE, 2011, 34 (01) :50-52

[32]

Mastrototaro J J, 2000, Diabetes Technol Ther, V2 Suppl 1, pS13, DOI 10.1089/15209150050214078

[33] Evaluating the Accuracy, Reliability, and Clinical Applicability of Continuous Glucose Monitoring (CGM): Is CGM Ready for Real Time? [J].

Mazze, Roger S. ;

Strock, Ellie ;

Borgman, Sarah ;

Wesley, David ;

Stout, Philip ;

Racchini, Joel .

DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (01) :11-18

[34] Clinical potential of insulin therapy in critically ill patients [J].

Mesotten, D ;

Van den Berghe, G .

DRUGS, 2003, 63 (07) :625-636

[35] Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial [J].

O'Connell, M. A. ;

Donath, S. ;

O'Neal, D. N. ;

Colman, P. G. ;

Ambler, G. R. ;

Jones, T. W. ;

Davis, E. A. ;

Cameron, F. J. .

DIABETOLOGIA, 2009, 52 (07) :1250-1257

[36]

Price D, 2013, DIABETES TECHNOL THE, V15, pA70

[37]

Ramchandani Neesha, 2011, J Diabetes Sci Technol, V5, P860

[38]

Rebrin Kerstin, 2010, J Diabetes Sci Technol, V4, P1087

[39] Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system [J].

Schiaffini, Riccardo ;

Brufani, Claudia ;

Russo, Beatrice ;

Fintini, Danilo ;

Migliaccio, Antonella ;

Pecorelli, Lia ;

Bizzarri, Carla ;

Lucidi, Vincenzina ;

Cappa, Marco .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (04) :705-710

[40] Hypoglycemia Unawareness Is Associated With Reduced Adherence to Therapeutic Decisions in Patients With Type 1 Diabetes Evidence from a clinical audit [J].

Smith, Charlotte B. ;

Choudhary, Pratik ;

Pernet, Andrew ;

Hopkins, David ;

Amiel, Stephanie A. .

DIABETES CARE, 2009, 32 (07) :1196-1198

← 1 2 3 4 5 →